Administration of Single-Dose Antibiotic Does Not Decrease Oronasal Fistula Rates After Primary Palatoplasty

Cleft Palate Craniofac J. 2022 Jan;59(1):14-21. doi: 10.1177/1055665621992653. Epub 2021 Feb 15.

Abstract

Objective: Oronasal fistula (ONF) is a known complication after primary palatoplasty (PP). Studies investigating the effect of perioperative antibiotics on fistula rates after PP are limited by inadequate sample size or reliance on self-reporting through national databases. In this study, the authors evaluated the association between single-dose perioperative antibiotics and postoperative fistula rates after PP at a single institution.

Design: A retrospective study.

Participants: Children younger than 2 years who underwent PP from April 2009 to September 2019 were included.

Interventions: Patients were divided into 2 categories: Group 1 received a single intraoperative dose of IV antibiotic, while group 2 did not.

Main outcome measure(s): Outcome measures included ONF formation, length of stay (LOS), and 30-day readmission rates. Multivariable firth logistic regression, quantile regression, and χ2 tests were performed.

Results: Of the 424 patients, 215 and 209 patients were in groups 1 and 2, respectively. The overall ONF rate was 1.9% among all patients. Patients in group 1 experienced an ONF rate of 3.3%, while patients in group 2 had an ONF rate of 0.5%. After correcting for confounding variables, the difference in ONF rates was not statistically different (P = .68). Median LOS was 35.7 hours and 35.5 hours (P = .17), while the rate of readmission within 30 days was 4.7% and 2.4% for group 1 and 2, respectively (P = .96).

Conclusions: Administration of a single-dose perioperative antibiotic did not decrease fistula formation after PP, nor did it affect the patient's LOS or 30-day readmission rate.

Keywords: antibiotics; oronasal fistula; palatoplasty.

MeSH terms

  • Anti-Bacterial Agents
  • Child
  • Cleft Palate* / surgery
  • Fistula*
  • Humans
  • Oral Fistula
  • Postoperative Complications / epidemiology
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents